Search studies by: All,

PEACHTREE – Sponsored by Clearside Biomedical, Inc.

Active Study | Duration: 24 weeks

PEACHTREE is a multicenter, masked, randomized Phase III clinical trial for the treatment of macular edema associated with non-infectious uveitis. This study evaluates... View study

ERM US 101 – Sponsored by Notal Vision, Inc.

Active Study | Duration: 12 months

ERM US 101 is a new study being conducted to compare the output of the ForeseeHome device in detecting and monitoring metamorphopsia (distortion) due to an epiretinal... View study

The Virginia Cancer Center, one of the leading cancer facilities on the East Coast, is collaborating with RGW on a study assessing the safety of the drug ASP2215. The... View study

This study involves refractions, ophthalmic exams and seven field fundus photography for two Infectious Disease specialists conducting a clinical trial on HIV-positive... View study

SD-OCT interpretation with possible Ophthalmic exams in the event the OCT shows abnormal results. This is in collaboration with Capital Digestive Care, which is... View study

For many years, we have known there is some correlation between one’s DNA makeup and Age-Related Macular Degeneration (AMD). This trial will study the mechanisms and... View study

This 12-month, Prospective, Randomized, active-controlled, open-label study to evaluate patient retention of Fingolimod vs. approved first-line disease modifying... View study

A year-long randomized, rater and dose blinded study to compare the efficacy and safety of Fingolimod 0.25mg and 0.5mg administered orally once daily with Glatiramer... View study